Akeso Biomedical, Inc. Employee Directory
Biotechnology ResearchMassachusetts, United States2-10 Employees
Akeso Biomedical, Inc., based in Waltham, Massachusetts, is a small, early-stage biotechnology company focused on developing new solutions for bacterial infections, microbial biofilms, and chronic wounds. It is pursuing a novel class of antimicrobial compounds labeled Fe3C, which aim to exhibit broad-spectrum activity against bacteria, along with a silk-based biomaterial technology licensed from Tufts University. The company’s lead product is a feed additive intended to prevent Campylobacter-related food poisoning in poultry. Campylobacter causes more cases of foodborne illness in the EU than Salmonella, E. coli, and Listeria combined, with approximately 280,000 UK cases and 1.3 million cases in the US each year. In 2017 Akeso announced a partnership with Banham Poultry to explore reducing Campylobacter in poultry using its Fe3C technology.